BOZEN, Italy, February 23 /PRNewswire/ -- Health Robotics and Can-Med today announced that they have signed a definitive agreement whereby Can-Med has acquired the exclusive distribution rights to Health Robotics' i.v.STATION robot in Armenia, Georgia, Kazakhstan, Uzbekistan, Azerbaijan, Iran, Mongolia, Turkmenistan, Kyrgyzstan, and Tajikistan. i.v.STATION is the world's first and only automated, point-of-care-distributed, and fail-safe robotic system for the sterile and accurate preparation of non-hazardous intravenous medications. In consideration for the acquisition of i.v.STATION five years' exclusive distribution rights, Can-Med has issued Health Robotics with purchase orders for an additional 129 i.v.STATION robots.
The primary challenges in today's I.V. Admixture operations are serious medication errors, high costs, turn-around time, waste, regulatory issues, lack of audit trails, motion injuries, space constraints and difficulty in maintaining adequate and trained staff. i.v.STATION was designed to address these issues and overcome the fact that until now, the range of products and technology available to mitigate these challenges has consisted of variations on the IV piggyback bag, outsourcing of IVs, and partial robotic solutions that have seen very limited adoption and success.
i.v.STATION represents a revolutionary approach in the quest for safe, accurate, efficient, and cost effective I.V. Admixtures. It offers unprecedented and life-critical patient safety, robotic precision and performance, all within a scalable and fail-safe architecture. We are committed to replicate the success of the CytoCare(TM) pay-per-use model with i.v.STATION beyond our home market in Turkey. The distributed nature of i.v.STATION permits its deployment where it matters most, at the direct patient care locations, stated Hilmi Sunay, General Manager of Can-Med I.V. Solutions.
We are very pleased to expand our strategic partnership with Can-Med beyond our current operations in Turkey where I have personally witnessed the success of the pay-per-use model introduced by Can-Med for our CytoCare robot during the recent go-live at Ankara Oncology Hospital and endorsed on national television by the Turkish Minister of Health by encouraging Turkish hospitals to adopt our technology.
(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)
We continue to witness Health Robotics' global dominance in the area of non-hazardous IV Admixtures by logging in excess of 900 purchase orders for i.v.STATION within 8 months of its announcement, more than 30 times the total 10+ year sales volume of all our competitor's non-hazardous I.V. Robots combined. Especially on this tough global economic climate, the creativity that Can-Med has exhibited with its pay-per-use model has been demonstrated to yield unprecedented results for our business by eliminating the capital expenditures that hospitals face when torn between the demonstrated benefits of our robots and the difficult economic times we live in nowadays, stated Werner Rainer, CEO of Health Robotics.
About Health Robotics:
Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing health care facilities around the world with robotic technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs] and i.v.STATION [non-hazardous IVs] have and will greatly contribute to ease global hospitals' clinics' growing pressures to improve patient safety through effective and efficient production of sterile, safe, accurate, and ready-to-administer IVs, to decrease life-threatening medication errors and cross-contamination risks, and to work more efficiently, increase throughput, reduce waste, and contain spiraling costs.
Can-Med is one of the leading I.V. solution providers in Turkey and parts of Eastern Europe, Middle East, and Central Asia. The company is the fastest growing business in Turkey within the fields of Pharmacy, I.V. Preparation and Administration, Oncology, Hemo-Dialysis, Periton-Dialisys, Diagnostic Testing, and Parenteral Nutrition. Can-Med has successfully introduced the world's first government-reimbursed pay-per-use model for robotic chemotherapy preparation and administration, with savings for both hospitals and the national government.
For additional information, please contact: Health Robotics Gaspar G. DeViedma Europe: +39-346-963-4934 USA: +1-609-980-7976 firstname.lastname@example.org Can-Med Hilmi Sunay Turkey: +90-5325279678 email@example.com
For additional information, please contact: Health Robotics, Gaspar G. DeViedma, Europe: +39-346-963-4934, USA: +1-609-980-7976, firstname.lastname@example.org; Can-Med, Hilmi Sunay, Turkey: +90-5325279678, email@example.com